Company Revenue

The company grew more than 40% in the third quarter of 2023 as it procedural solutions continue winning significant market...

The company grew nearly 29% in the third quarter of 2023, notching its sixth consecutive quarter of record revenues....

The company grew in the high-single-digits in the third quarter of 2023, driven by market recovery and improving operational performance....

The company grew in the mid-single-digits for the third quarter of 2023, driven by new products and better-than-expected orthobiologics sales....

The company grew in the high-single-digits in the third quarter of 2023, driven by new products and robotic procedures....

The company's 3Q23 orthopedic sales declined by nearly 10% due to continued competitive pressure and an exit from the Chinese...

The company's orthopedic sales grew in the mid-single-digits for the third quarter of 2023 and displayed newfound resiliency. ...

The company grew in the low single digits in 3Q23 and announced a two-year restructuring of its orthopedics business....

The company grew more than 20% in the first half of 2023 primarily as a result of volume won during...

The company grew in the high single digits in the first half of 2023 as it overcome supply challenges domestically...